1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 1: Duration between initial and recurrent hemorrhage in patients with SCAVMs
Duration No. (n = 35) Percentage
<7 Days 6 18
8–31 Days 5 14
1–6 Months 2 5.7
6 Months to 1 year 4 11
1–2 Years 2 5.7
2–3 Years 3 8.6
>3 Years 13 37
Duration	No. (n = 35)	Percentage
<7 Days	6	18
8–31 Days	5	14
1–6 Months	2	5.7
6 Months to 1 year	4	11
1–2 Years	2	5.7
2–3 Years	3	8.6
>3 Years	13	37